Bond Screener
AbbVie
LEI FR5LCKFTG8054YNNRU85, SWIFT ABBVUS44XXX
Organization name
AbbVie, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
78,597 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including multiple sclerosis, parkinson's, and alzheimer's disease.
|
General information
-
Organization nameAbbVie, Inc.
-
Organization statusOperating organization
-
Address1 North Waukegan Road, North Chicago, USA, 60064
-
Site
-
IR Site
News
-
AbbVie: Regulation Fd Disclosure03/09/2026
-
Analyst Raises Price Target for AbbVie Inc. (NYSE:ABBV) Amid Strong Institutional Investor Confidence20/08/2026
-
New issues: AbbVie issued international bonds (US00287YEL92, US00287YEK10, US00287YEM75, US00287YEN58, US00287YEP07, US00287YEQ89, US00287YER62, US00287YES46, US00287YET29) in the amount of USD 500, USD 1000, USD 1250, USD 1500, USD 1250, USD 1500, USD 1000, USD 1500, USD 500 mln maturing in 2028, 2028, 2030, 2031, 2033, 2036, 2038, 2056, 2066 respectively.07/08/2026
-
AbbVie (NYSE: ABBV) Exceeds Q2 2026 Earnings and Revenue Forecasts31/07/2026
-
AbbVie: Submission Of Matters To A Vote Of Security Holders08/05/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameAbbVie, Inc.
-
Organization statusOperating organization
-
Address1 North Waukegan Road, North Chicago, USA, 60064
-
Site
-
IR Site
Codes
-
LEIFR5LCKFTG8054YNNRU85
-
SWIFTABBVUS44XXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001551152
-
EIN32-0375147
